Earnings Call · Q4 FY2025·2026-02-27

Q4 25EPS +16.67%·Rev n/aQ3 25EPS +21.43%·Rev n/aQ2 25EPS +47.06%·Rev n/aQ1 25EPS +40.00%·Rev n/a⚠ consensus missing

Amneal Pharmaceuticals, Inc. AMRX

Anthony DiMeo — Investor Relations

Chirag K. Patel — Chief Executive Officer

Chintu Patel — Chief Operating Officer

Anastasios G. Konidaris — Chief Financial Officer

−4.7%1d on move date−4.2% vs SPY3d−8.1%5d−8.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMRX calls or request research access.

More AMRX calls Browse calls Request research access